A 50-year-old female presented with bilateral cervical arteriosclerosis and right-sided plaque formation, after 25 d of treatment with rosuvastatin calcium tablets (20 mg, po, qn), the patient developed temporomandibular joint dislocation, the adverse reactions occurred again after giving manipulative repositioning. The patients were healthy, had no history of trauma and related diseases in stomatology, no history of drug allergy, patients did not open their mouth loudly at the onset of the disease, no external factors affecting the use of drugs during the combined use of other drugs. It was considered "very likely" that the dislocation of the jaw joint was caused by rosuvastatin calcium tablets. The patients were followed up for 3 months after the treatment of manipulative repositioning and other treatments, did not have any further dislocation of the temporomandibular joint dislocation. It is suggested that when using rosuvastatin calcium in clinical practice, attention should be paid to strengthening drug observation to ensure drug safety.

1.陈萍, 俞律峰, 邹德荣. 颞下颌关节脱位保守治疗与手术治疗的研究进展[J]. 口腔材料器械杂志, 2022, 31(3): 205-209. [Chen P, Yu LF, Zou DR. Research progress in conservative and surgical treatment of temporomandibular joint dislocation[J]. Chinese Journal of Dental Materials and Devices, 2022, 31(3): 205-209.] DOI: 10.11752/j.kqcl. 2022.03.10.

2.宋昊天, 杨驰. 45例复发性颞下颌关节前脱位的分类及治疗探讨[J]. 中国口腔颌面外科杂志, 2019, 17(4): 352-355. [Song HT, Yang C. Classification and treatment for recurrent anterior dislocation of temporomandibular joint on 45 cases[J]. China Journal of Oral and Maxillofacial Surgery, 2019, 17(4): 352-355.] DOI: 10.19438/j.cjoms. 2019.04.015.

3.张建全, 高丽荣, 聂廷洪, 等. 口腔急诊颞下颌关节脱位临床特点及分析[J]. 医学理论与实践, 2021, 34(16): 2896-2897. [Zhang JQ, Gao LR, Nie TH, et al. Clinical characteristics and analysis of temporomandibular joint dislocation in oral emergency[J]. The Journal of Medical Theory and Practice, 2021, 34(16): 2896-2897.] DOI: 10. 19381/j.issn.1001-7585.2021.16.075.

4.孙磊, 包博, 牛忠英, 等. 口腔急诊颞下颌关节脱位发病特点及相关因素分析[J]. 口腔颌面修复学杂志, 2016, 17(2): 74-77. [Sun L, Bao B, Niu ZY, et al. Clinical characteristics and analysis of temporomandibular joint dislocation in oral emergency[J]. The Journal of Medical Theory and Practice, 2016, 17(2): 74-77.] DOI: 10.3969/j.issn.1009-3761.2016.02.003.

5.胡凤霞, 时平, 王月平, 等. 甲氧氯普胺过量致颞下颌关节脱位2例[J]. 医药导报, 2000, 19(6): 610. [Hu FX, Shi P, Wang YP, et al. Dislocation of temporomandibular joint caused by excessive metoclopramide[J]. Herald of Medicine, 2016, 17(2): 74-77.] DOI: 10.3870/j.issn. 1004-0781.2000.06.099.

6.陈玉社, 公丕欣. 普瑞博思引起反复颞下颌关节脱位1例报告[J]. 泰山医学院学报, 2001, 22(2): 91. [Chen YS, Gong PX. Recurrent dislocation of temporomandibular joint caused by prepulsid report of 1 case[J]. Ningxia Medical Journal, 2001, 22(2): 91.] DOI: 10.3969/j.issn. 1004-7115.2001.02.049.

7.林常红. 局麻药中毒抽搐引起颞下颌关节脱位1例[J]. 宁夏医学杂志, 2004, 26(8): 496. [Lin CH. Dislocation of temporomandibular joint caused by local anesthetic intoxication and convulsion in 1 case[J]. Ningxia Medical Journal, 2004, 26(8): 496.] DOI: 10.3969/j.issn.1001-5949.2004.08.043.

8.国家药品监督管理局. 关于发布个例药品不良反应收集和报告指导原则的通告(国家药监局2018年第131号) [EB/OL].（2018-12-21）[2023-02-01]. https://www.nmpa.gov.cn/xxgk/ ggtg/ qtggtg/20181221172901438. html.

9.Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions[J].Clin Pharmacol Ther, 1981, 30(2): 239-245.] DOI: 10.1038/clpt.1981.154.

10.王富收. 瑞舒伐他汀钙的不良反应及合理应对[J]. 中国卫生标准管理, 2016, 7(19): 102-105. [Wang FS. The adverse effects of calcium rosuvastatin and appropriate responses[J]. China Health Standard Management, 2016, 7(19): 102-105.] DOI: 10.3969/j.issn.1674-9316.2016. 19.071.

11.刘淑芳, 张青山, 金仲品. 他汀类调脂药的肌溶解作用1例报告[J]. 药物流行病学杂志, 2003, 12(5): 274-275. [Liu SF, Zhang QS, Jin ZP. A case report of myolysis induced by statins[J]. Chinese Journal of Pharmacoepidemiology, 2003, 12(5): 274-275.] DOI: 10. 3969/j.issn.1005-0698.2003.05.020.

12.庞广杰, 王金鹏, 李俊, 等. 瑞舒伐他汀致发热不良反应1例[J]. 中国循证心血管医学杂志, 2013, 5(5): 531. [Pang GJ, Wang JP, Li J, et al. Fever due to rosuvastatin in 1 case[J]. Chinese Journal of Evidence-Based Cardiovascular Medicine, 2013, 5(5): 531.] DOI: 10.3969/j. 1674-4055.2013.05.35.

13.李晋, 赵树进. 他汀类药物致转氨酶升高1例[J].中国药物警戒, 2011, 8(9): 573-574. [Li J, Zhao SJ. One case of high level of glutamic-pyruvic transaminase induced by statins[J]. Chinese Journal of Pharmacovigilance, 2011, 8(9): 573-574.] DOI: 10.3969/j.issn.1672- 8629.2011.09.023.

14.高千秋, 张浩嘉. 302例他汀类药物相关肌肉系统损害的文献分析[J]. 中国药物警戒, 2018, 15(8): 476-480. [Gao QQ, Zhang HJ. Literature analysis of 302 cases of statin-related muscle system damage[J]. Chinese Journal of Pharmacovigilance, 2018, 15(8): 476-480.] DOI: 10.3969/j.issn.1672-8629.2018.08.007.

15.袁亚辉, 雷招宝. 瑞舒伐他汀致不良反应41例国内外病例报告分析[J]. 抗感染药学, 2016, 13(6): 1294-1298. [Yuan YH, Lei ZB. Analysis of 41 cases of adverse drug reactions induced by rosuvastatin[J]. Anti-infective Pharmacy, 2016, 13(6): 1294-1298.] DOI: 10.13493/j.issn. 1672-7878.2016.06-027.

16.吴玉怀, 张传林, 刘建平. 他汀类药物与脊柱骨折相关关系的Meta分析[J]. 当代护士, 2019, 26(10): 31-35. [Wu YH, Zhang CL, Liu JP. Meta-analysis of the association between statins and spinal fractures[J]. Modern Nurse, 2019, 3726(10): 31-35.] DOI: CNKI:SUN:DDHZ. 0.2019-10-011.

17.陈崇泽, 陈代星, 陈孝伟. 瑞舒伐他汀致不良反应文献回顾分析[J]. 药物评价研究, 2014, 37(6): 572-575. [Chen CZ, Chen DX, Chen XW. Literature review of adverse drug reactions induced by rosuvastatin[J]. Drug Evaluation Studies, 2014, 37(6): 572-575.] DOI: 10.7501/j. issn.1674-6376.2014.06.024.

18.朱扬媚, 曹建刚, 周玉生. 基因检测在降脂药物个体化治疗中的应用[J]. 中国药房, 2023, 34(9): 1147-1152. [Zhu YM, Cao JG, Zhou YS. Application of gene detection in individualized treatment of lipid lowering drugs[J].China Pharmacy, 2023, 34(9): 1147-1152.] DOI: 10.6039/j.issn. 1001-0408.2023.09.23.